Phase 1 Lung Cancer Trial, Recruiting (NCT02570815)

Phase 1 Lung Cancer Trial, Recruiting NCT02570815 Sponsor: St. Joseph's Healthcare Hamilton Condition: Lung Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT02570815 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Lung Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults over 18 years of age.
People whose lung tumor is smaller than 3 centimeters (about the size of a grape).
People diagnosed with Stage 1 Non-Small Cell Lung Cancer (NSCLC), which is an early stage of a specific type of lung cancer.
People whose CT scan shows the tumor is located within a single section of the lung, making a type of lung surgery called segmental resection possible (confirm with trial site).

Who may not be able to join:

People who have a known allergy or sensitivity to ICG (a medical dye), sodium iodide, or iodine.
Women who are currently pregnant or breastfeeding.
Women who are capable of becoming pregnant and are not currently using an adequate form of birth control.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 12 July 2026

Phase 1: approximately ~10% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Principal Investigator: Waël C. Hanna, MDCM, MBA, FRCSC, St. Joseph's Healthcare Hamilton / McMaster University

Phone: 905-522-1155

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT02570815

Sponsor: St. Joseph's Healthcare Hamilton

Phase: Phase 1

Status: Recruiting

Condition: Lung Cancer

Trial contact: 905-522-1155

More information: https://clinicaltrials.gov/study/NCT02570815

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults over 18 years of age.
People whose lung tumor is smaller than 3 centimeters (about the size of a grape).
People diagnosed with Stage 1 Non-Small Cell Lung Cancer (NSCLC), which is an early stage of a specific type of lung cancer.
People whose CT scan shows the tumor is located within a single section of the lung, making a type of lung surgery called segmental resection possible (confirm with trial site).

Who may not be able to join:

People who have a known allergy or sensitivity to ICG (a medical dye), sodium iodide, or iodine.
Women who are currently pregnant or breastfeeding.
Women who are capable of becoming pregnant and are not currently using an adequate form of birth control.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 12 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 1

Sponsor

St. Joseph's Healthcare Hamilton

Registry

ClinicalTrials.gov

Start date

1 October 2016

Est. completion

1 October 2026

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Feasibility of using NIF-guidance in robotic pulmonary segmentectomy for early-stage lung cancer will be evaluated using items 1, 2, and 3 of a 7-item binary rating scale. An score of 3/7 for these items will indicate success.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov